MedTrace Logo

Effect of Prophylactic Antibiotics for Hysterosalpingography on Post Procedure Morbidity

NCT04234945 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2022-01-04

No results posted yet for this study

Summary

The study will be a parallel randomised trial. There are two groups. The first group will be given prophylactic antibiotics before a procedure (hysterosalpingography) and the second group will be given a placebo(multivitamin). Outcomes will then be assessed.

Conditions

  • Infertility, Female
  • Pelvic Inflammatory Disease

Interventions

DRUG

Doxycycline Capsule

Group A will be the study group and will be given oral Doxycycline capsule 100mg bd for 3/7. She will be instructed to commence the medication on day 7 of her next menstrual cycle and hysterosalpingogram will be done within the proliferative phase (Day 10) of the same menstrual cycle after cessation of bleeding.

DRUG

Multivitamins W/Iron Tab

Group B will be the study group and will be given oral Multivitamin capsule i bd for 3/7. She will be instructed to commence the medication on day 7 of her next menstrual cycle and hysterosalpingogram will be done within the proliferative phase (Day 10) of the same menstrual cycle after cessation of bleeding

Sponsors & Collaborators

  • Ahmadu Bello University Teaching Hospital

    lead OTHER

Principal Investigators

  • Anisah Yahya, MBBS · Ahmadu Bello University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-13
Primary Completion
2022-10-31
Completion
2022-12-31

Countries

  • Nigeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04234945 on ClinicalTrials.gov